Mr. Han Ton-that, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6305 Castle Place, Suite 1-a, Falls Church, VA 22044 Phone: 703-534-9090 Fax: 703-534-9191 |
Dr. Maurice Atiyeh, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 6400 Arlington Blvd Ste 940, Falls Church, VA 22042 Phone: 703-241-1010 |
Dr. Jesse K Liu, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 201 N Washington St, Falls Church, VA 22046 Phone: 703-237-4000 Fax: 703-531-1689 |
Dr. Robert W Sjogren Jr., M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 201 N Washington St, Kaiser Permanente Falls Church Medical Center, Falls Church, VA 22046 Phone: 703-237-4000 Fax: 703-531-1708 |
Dr. Brian J Swansiger, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 201 Notrth Washington Street, Falls Church, VA 22046 Phone: 703-237-4020 Fax: 703-536-1395 |
Dr. James Nelson Cooper, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-3582 |
News Archive
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced top line results from its randomized, double-blind, placebo-controlled, Phase 2b clinical trial of Synavive in rheumatoid arthritis.
According to the Australasian College of Cosmetic Surgery, a just-released study of medical negligence claims between 2002 and 2008 published in the Medical Journal of Australia underlines the importance that codes of practice can play in ensuring that a proper process is observed to obtain informed consent for cosmetic surgical procedures.
According to a literature review in the July issue of the Journal of the American Academy of Orthopaedic Surgeons, patients' activity level is a strong predictor for how well they will do with certain treatments and how well they recover from injuries after treatment. Patients are encouraged to ask their orthopaedic surgeon if activity level is an important factor in their treatment decision.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Oxycodone and Aspirin Tablets USP, 4.8355 mg/325 mg, based on an agreement with licensing partner Coastal Pharmaceuticals.
› Verified 1 days ago